- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 12.97M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 14.18M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 4.54M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $23K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$21.95M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.64M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $168.15M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $189.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $141.68M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $163.31M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$17.78M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$8.21M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $48.81M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $49.55M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $50.05M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $51.49M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $188.85M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $210.74M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $191.73M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $214.8M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.66 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$2.28 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.66 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$2.28 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $6.18M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $3.6M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $24.6M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $5.92M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$23.48M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.33M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$25.27M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$8.54M |